BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17633224)

  • 21. 20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension.
    Williams JM; Murphy S; Burke M; Roman RJ
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):336-44. PubMed ID: 20930591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 20-Hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases.
    Elshenawy OH; Anwar-Mohamed A; El-Kadi AO
    Curr Drug Metab; 2013 Jul; 14(6):706-19. PubMed ID: 23701160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of 20-HETE in cardiovascular diseases and its risk factors.
    Waldman M; Peterson SJ; Arad M; Hochhauser E
    Prostaglandins Other Lipid Mediat; 2016 Sep; 125():108-17. PubMed ID: 27287720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target.
    Elshenawy OH; Shoieb SM; Mohamed A; El-Kadi AO
    Pharmaceutics; 2017 Feb; 9(1):. PubMed ID: 28230738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taking the 20-HETE out of the cardiovascular system: the potential of 20-HETE synthesis inhibitors.
    Doggrell SA
    Curr Opin Investig Drugs; 2005 Sep; 6(9):901-6. PubMed ID: 16187690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial cell function: biologic and physiologic functions in health and disease.
    Shireman PK; Pearce WH
    AJR Am J Roentgenol; 1996 Jan; 166(1):7-13. PubMed ID: 8571908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Regulation of vasomotor tone].
    Longrois D; Guinot PG; Depoix JP
    Ann Fr Anesth Reanim; 2012 May; 31 Suppl 1():S25-30. PubMed ID: 22721518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of vascular tone: role of 20-HETE in the modulation of myogenic reactivity.
    Kaley G
    Circ Res; 2000 Jul; 87(1):4-5. PubMed ID: 10884363
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased production of 15-hydroxyeicosatetraenoic acid by placentae from pregnancies complicated by pregnancy-induced hypertension.
    Mitchell MD; Koenig JM
    Prostaglandins Leukot Essent Fatty Acids; 1991 May; 43(1):61-2. PubMed ID: 1881943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The phenomenon of reactive vasodilation in pregnancy.
    Dolezal A; Figar S
    Am J Obstet Gynecol; 1965 Dec; 93(8):1137-43. PubMed ID: 5847910
    [No Abstract]   [Full Text] [Related]  

  • 31. The measurement of tension in vascular smooth muscle.
    BURTON AC; STINSON RH
    J Physiol; 1960 Sep; 153(2):290-305. PubMed ID: 13689275
    [No Abstract]   [Full Text] [Related]  

  • 32. GPR75 Identified as the First 20-HETE Receptor: A Chemokine Receptor Adopted by a New Family.
    Fan F; Roman RJ
    Circ Res; 2017 May; 120(11):1696-1698. PubMed ID: 28546348
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyp2c44-mediated decrease of 15-HETE exacerbates pulmonary hypertension.
    Fülöp GÁ; Yabluchanskiy A
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H251-H255. PubMed ID: 28626080
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.
    McPherson KC; Shields CA; Poudel B; Fizer B; Pennington A; Szabo-Johnson A; Thompson WL; Cornelius DC; Williams JM
    Am J Physiol Renal Physiol; 2019 Feb; 316(2):F316-F327. PubMed ID: 30539649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Roles of 20-HETE on physiologic and pathologic regulation in organism].
    Zhang D; Huo HL; Zhang YN; Zeng QH
    Sheng Li Ke Xue Jin Zhan; 2007 Apr; 38(2):120-4. PubMed ID: 17633224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progress of studies in 20-hydroxyeicosatetraenoic acid on vascular endothelium].
    Li H; Zhu Y
    Sheng Li Ke Xue Jin Zhan; 2013 Feb; 44(1):1-5. PubMed ID: 23671992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.
    Miyata N; Roman RJ
    J Smooth Muscle Res; 2005 Aug; 41(4):175-93. PubMed ID: 16258232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11.
    Powell PK; Wolf I; Jin R; Lasker JM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1327-36. PubMed ID: 9618440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P-450 metabolites of arachidonic acid in the control of cardiovascular function.
    Roman RJ
    Physiol Rev; 2002 Jan; 82(1):131-85. PubMed ID: 11773611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 20-HETE in neovascularization.
    Chen L; Ackerman R; Guo AM
    Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):63-8. PubMed ID: 22227460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.